Status:
UNKNOWN
The Biological Basis of Phlegm Dampness Syndrome in Patients With Ischemic Stroke：A Saliva and Urine Proteomics Study
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Collaborating Sponsors:
Guangzhou Cadre Health Management Center
Conditions:
Protein; Disease
Eligibility:
All Genders
35-80 years
Brief Summary
This study aimed to explorie the biological basis of phlegm-dampness syndrome in patients with ischemic stroke using proteomics research techniques of urine and saliva.
Detailed Description
Stroke is the disease with the highest mortality and disability in China, and the annual incidence of ischemic stroke is the highest. Atherosclerosis is the main cause of ischemic stroke. According to...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ischemic stroke
- Aged 35-80-year-old.
- Agree to participate in clinical research and sign informed consent.
Exclusion
- Clinical diagnosis of cerebral hemorrhage;
- With severe infection, severe renal dysfunction, and tumor;
- Clinical diagnosis of acute oral inflammation, oral ulcers, or urinary infections;
- Clinical diagnosis of systemic lupus erythematosus and rheumatoid arthritis;
- Pregnant women or lactating mothers
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04472754
Start Date
August 1 2020
End Date
June 30 2021
Last Update
July 15 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.